These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7530204)

  • 1. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    Schreiber R; Brocco M; Millan MJ
    Eur J Pharmacol; 1994 Oct; 264(1):99-102. PubMed ID: 7530204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics.
    Sánchez C; Arnt J
    Behav Pharmacol; 2000 Jun; 11(3-4):291-8. PubMed ID: 11103883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.
    Dekeyne A; Iob L; Millan MJ
    Neuropharmacology; 2003 Apr; 44(5):604-15. PubMed ID: 12668046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
    Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
    J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
    Hitchcock JM; Lister S; Fischer TR; Wettstein JG
    Behav Brain Res; 1997 Oct; 88(1):43-9. PubMed ID: 9401707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?
    Arnt J
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):117-25. PubMed ID: 8935806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
    Fijał K; Popik P; Nikiforuk A
    Psychopharmacology (Berl); 2014 Jan; 231(1):269-81. PubMed ID: 23954911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA; McCloskey TC; Kehne JH
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):107-16. PubMed ID: 8935805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
    Willins DL; Berry SA; Alsayegh L; Backstrom JR; Sanders-Bush E; Friedman L; Roth BL
    Neuroscience; 1999; 91(2):599-606. PubMed ID: 10366017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
    Bergqvist PB; Dong J; Blier P
    Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
    Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD
    J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.